🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/11/2005 | 30,66 | 30,77 | 30,32 | 30,51 | -0,24% | 1,47% | 38.098 |
| 08/11/2005 | 30,69 | 31,07 | 30,43 | 30,58 | -1,57% | 2,07% | 56.960 |
| 07/11/2005 | 31,37 | 32,00 | 30,69 | 31,07 | +0,00% | 4,18% | 179.242 |
| 04/11/2005 | 29,94 | 31,82 | 29,91 | 31,07 | +4,40% | 6,37% | 229.069 |
| 03/11/2005 | 30,88 | 31,07 | 29,01 | 29,76 | -3,64% | 6,67% | 437.432 |
| 02/11/2005 | 31,70 | 32,38 | 28,63 | 30,88 | -2,94% | 11,81% | 124.206 |
| 01/11/2005 | 32,38 | 32,75 | 31,82 | 31,82 | -1,73% | 2,89% | 122.549 |
| 31/10/2005 | 32,94 | 33,13 | 31,82 | 32,38 | -1,14% | 3,98% | 113.813 |
| 28/10/2005 | 33,57 | 33,99 | 32,38 | 32,75 | -1,91% | 4,79% | 94.497 |
| 27/10/2005 | 33,31 | 35,18 | 33,31 | 33,39 | +0,22% | 5,62% | 290.464 |
| 26/10/2005 | 31,59 | 33,50 | 31,37 | 33,31 | +5,33% | 6,75% | 212.745 |
| 25/10/2005 | 31,82 | 32,19 | 31,44 | 31,63 | -0,59% | 2,35% | 51.376 |
| 24/10/2005 | 31,63 | 32,94 | 31,63 | 31,82 | +0,59% | 4,14% | 55.143 |
| 21/10/2005 | 33,13 | 33,13 | 31,44 | 31,63 | -3,76% | 5,08% | 106.653 |
| 20/10/2005 | 33,50 | 33,87 | 32,86 | 32,86 | -2,44% | 3,02% | 78.707 |
| 19/10/2005 | 32,75 | 34,81 | 32,00 | 33,69 | +2,86% | 8,57% | 234.706 |
| 18/10/2005 | 34,25 | 34,44 | 32,56 | 32,75 | -4,68% | 5,46% | 278.975 |
| 17/10/2005 | 32,75 | 34,44 | 32,75 | 34,36 | +4,32% | 5,14% | 320.947 |
| 14/10/2005 | 31,52 | 33,69 | 31,52 | 32,94 | +2,92% | 6,89% | 332.676 |
| 13/10/2005 | 32,71 | 33,69 | 31,55 | 32,00 | -2,17% | 6,52% | 406.147 |
| 12/10/2005 | 33,57 | 33,69 | 32,68 | 32,71 | -2,89% | 3,01% | 338.286 |
| 11/10/2005 | 34,44 | 34,44 | 33,50 | 33,69 | -2,17% | 2,72% | 236.576 |
| 10/10/2005 | 33,31 | 34,62 | 33,16 | 34,44 | +4,55% | 4,38% | 526.960 |
| 07/10/2005 | 33,13 | 33,69 | 32,38 | 32,94 | -2,22% | 3,95% | 235.775 |
| 06/10/2005 | 34,62 | 34,62 | 32,75 | 33,69 | -2,17% | 5,41% | 362.732 |
| 05/10/2005 | 35,75 | 36,31 | 34,29 | 34,44 | -3,16% | 5,65% | 404.277 |
| 04/10/2005 | 36,68 | 36,87 | 34,81 | 35,56 | -3,06% | 5,61% | 221.561 |
| 03/10/2005 | 38,07 | 38,25 | 35,93 | 36,68 | -3,35% | 6,10% | 429.257 |
| 30/09/2005 | 32,94 | 38,03 | 32,75 | 37,95 | +15,23% | 16,02% | 1.656.433 |
| 29/09/2005 | 32,56 | 33,16 | 31,82 | 32,94 | +1,15% | 4,14% | 246.034 |